Ahn JS - Search Results

1

Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09).

Cho JH, Lim SH, An HJ, Kim KH, Park KU, Kang EJ, Choi YH, Ahn MS, Lee MH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Cho JH, et al. Among authors: ahn js, ahn mj, ahn ms. J Clin Oncol. 2020 Feb 10;38(5):488-495. doi: 10.1200/JCO.19.00931. Epub 2019 Dec 11. J Clin Oncol. 2020. PMID: 31825714 Free PMC article. Clinical Trial.

2

GM-CSF production by epithelial cell line: upregulation by ultraviolet A.

Park KC, Jung HC, Hwang JH, Youn SW, Ahn JS, Park SB, Kim KH, Chung JH, Youn JI. Park KC, et al. Among authors: ahn js. Photodermatol Photoimmunol Photomed. 1997 Aug;13(4):133-8. doi: 10.1111/j.1600-0781.1997.tb00216.x. Photodermatol Photoimmunol Photomed. 1997. PMID: 9453081

3

Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma.

Kim NK, Im SA, Kim DW, Lee MH, Jung CW, Cho EK, Lee JT, Ahn JS, Heo DS, Bang YJ. Kim NK, et al. Among authors: ahn js. Cancer. 1999 Oct 1;86(7):1109-15. doi: 10.1002/(sici)1097-0142(19991001)86:7<1109::aid-cncr3>3.0.co;2-g. Cancer. 1999. PMID: 10506693 Clinical Trial.

4

The changes of serum soluble intercellular adhesion molecule-1 after systemic steroid treatment in vitiligo.

Hwang JH, Ahn JS, Kim SD, Lim JG, Kim YG, Kim KH, Park KC. Hwang JH, et al. Among authors: ahn js. J Dermatol Sci. 1999 Dec;22(1):11-6. doi: 10.1016/s0923-1811(99)00035-3. J Dermatol Sci. 1999. PMID: 10651224

5

Vitiligo skin types in Koreans.

Ahn JS, Lim JG, Kim SD, Kim KH, Park KC. Ahn JS, et al. J Dermatol. 2000 May;27(5):324-8. doi: 10.1111/j.1346-8138.2000.tb02175.x. J Dermatol. 2000. PMID: 10875199

6

Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells.

Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K. Lee J, et al. Among authors: ahn js. Biochem Biophys Res Commun. 2005 Aug 26;334(2):313-8. doi: 10.1016/j.bbrc.2005.06.093. Biochem Biophys Res Commun. 2005. PMID: 16005433

7

High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization.

Ahn JS, Park S, Im SA, Yoon SS, Lee JS, Kim BK, Bang SM, Cho EK, Lee JH, Jung CW, Kim HC, Seong CM, Lee MH, Kim CS, Lee KS, Lee JA, Ahn MJ. Ahn JS, et al. Among authors: ahn mj. Korean J Intern Med. 2005 Sep;20(3):224-31. doi: 10.3904/kjim.2005.20.3.224. Korean J Intern Med. 2005. PMID: 16295781 Free PMC article. Clinical Trial.

8

Interferon-alpha resistance can be reversed by inhibition of IFN-alpha-induced COX-2 expression potentially via STAT1 activation in A549 cells.

Lee J, Jung HH, Im YH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K. Lee J, et al. Among authors: ahn js. Oncol Rep. 2006 Jun;15(6):1541-9. Oncol Rep. 2006. PMID: 16685393

9

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer.

Park KW, Ahn JS, Park YS, Lee J, Kang JH, Park JO, Lim HY, Im YH, Kang WK, Park K, Lee SI. Park KW, et al. Among authors: ahn js. Cancer Chemother Pharmacol. 2007 Jan;59(1):17-21. doi: 10.1007/s00280-006-0253-2. Epub 2006 May 24. Cancer Chemother Pharmacol. 2007. PMID: 16721549 Clinical Trial.

10

Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?

Park BB, Park JO, Kim H, Ahn YC, Choi YS, Kim K, Kim J, Shim YM, Ahn JS, Park K. Park BB, et al. Among authors: ahn js, ahn yc. Lung Cancer. 2006 Sep;53(3):323-30. doi: 10.1016/j.lungcan.2006.05.024. Epub 2006 Jul 17. Lung Cancer. 2006. PMID: 16844258

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,356 results

Search Page